AURX Nuo Therapeutics, Inc.: institutional ownership and insider trading
1 funds reported holding $4.28K of Nuo Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 0 funds selling out; over the last 12 months insiders bought $9.55K and sold $300K on the open market.
Largest institutional holders of AURX
- Ancora Advisors LLC — $4.28K
Recent AURX insider trades
- Aug 28, 2026: Jorden David Emerson bought 8,773 shares ($9.55K)
- Nov 28, 2025: Jorden David Emerson sold 200,000 shares ($300K)
- Jul 30, 2025: Sheedy Charles E bought 133,333 shares ($200K)
5%+ owners
- Pittman Scott M.: 11.6% (Schedule 13D/A, filed Jun 3, 2026)